The statistics on oral cancer are direct and important: approximately 54,000 Americans are diagnosed with oral or oropharyngeal cancer every year. The overall five-year survival rate sits at approximately 67 percent. But that number obscures a critical disparity: the five-year survival rate for oral cancer detected at Stage 1 exceeds 80 percent, while Stage 4 survival is below 30 percent. The difference between those outcomes - in the majority of cases - comes down to whether routine professional screening was occurring when the lesion was still early and small.
At Mur-Len Family Dentistry in Olathe, oral cancer screening is a standard part of every comprehensive examination. It costs nothing extra, adds only a few minutes to your appointment, and is the clinical mechanism through which early-stage lesions are identified before they progress. It is not optional, not an add-on, and not something patients have to ask for - it happens at every exam as a matter of standard care.
Schedule a comprehensive exam or call (913) 353-4001. Oral cancer screening is included.
The Epidemiology of Oral Cancer - Why Screening Matters for Everyone
Understanding who gets oral cancer is essential context for understanding why universal screening - not risk-stratified screening - is the recommended standard of care.
Historically, oral cancer affected a relatively predictable demographic: older men who used tobacco and consumed significant alcohol. Screening protocols were largely directed toward identifying lesions in this high-risk population. This demographic profile has changed substantially over the past two decades.
HPV-related oropharyngeal cancer has emerged as the fastest-growing oral/oropharyngeal cancer category in the United States. These cancers predominantly affect the base of the tongue, tonsils, and posterior pharynx, and their epidemiology is fundamentally different from tobacco-related cancers. HPV-positive oropharyngeal cancers occur at higher rates in:
- Patients under 50 - younger than the traditional oral cancer demographic
- Non-smokers and light smokers
- Patients with higher socioeconomic status and education levels
- Both men and women, though men are still more commonly affected
This demographic shift means that the patients walking into dental offices who do not "look like" oral cancer patients - young, healthy, non-smoking professionals in their 40s and 50s - can and do develop these cancers. The American Dental Association has accordingly moved toward recommending universal oral cancer screening regardless of individual risk factors, and Mur-Len Family Dentistry implements this recommendation at every examination.
What the Oral Cancer Examination at Mur-Len Covers
The systematic oral cancer examination at Mur-Len Family Dentistry is comprehensive, following the ADA-recommended examination sequence:
Extraoral Examination
Before examining inside the mouth, Dr. Warya or Dr. Warya examines the face and neck visually and manually. Facial asymmetry or changes in surface texture that might indicate a mass or swelling beneath the skin are noted. The cervical lymph nodes along the sides of the neck are palpated systematically - enlarged, firm, or tender lymph nodes can indicate infection or malignant involvement and are a critical finding that might not be apparent inside the mouth itself. The parotid and submandibular salivary glands are palpated for masses or asymmetric enlargement.
Lip Examination
The lips are examined externally for any surface changes, ulcerations, or masses. The labial mucosa - the moist inner surface of the upper and lower lips - is everted and examined for any discoloration, white or red patches, or textural abnormalities. The commissures (corners of the mouth) are examined for inflammatory changes or lesions.
Buccal Mucosa Examination
Both cheeks are examined with the cheek gently retracted using a mouth mirror to expose the full buccal mucosa surface to the posterior. The occlusal line - the area of the cheek that contacts the biting surfaces - is examined carefully, as this area shows early changes from tobacco use and is a common site for tobacco-related lesions.
Tongue Examination - The Most Critical Area
The tongue is among the most important and most frequently affected sites in oral cancer. The examination must cover all three functional surfaces:
The dorsal surface (top of the tongue) is examined for changes in texture, color, or the papillae pattern. The ventral surface (underside of the tongue) is examined by having the patient touch the tip of their tongue to the roof of their mouth. This area and the anterior floor of mouth are the most common locations for squamous cell carcinoma of the tongue, and they are frequently not examined at all in practices without systematic protocol.
The lateral borders of the tongue are examined by grasping the tongue with gauze and gently extending it to each side. This visualization is not achievable without the gauze technique - the natural position of the tongue does not allow adequate lateral border visualization. The lateral borders are the single most common site of intraoral squamous cell carcinoma.
Floor of the Mouth
The floor of the mouth is examined visually when the tongue is elevated and bimanually by placing one gloved finger under the tongue and a finger of the other hand beneath the chin. This bimanual palpation identifies firmness or masses in the floor of mouth tissue that visual inspection cannot detect. Floor of mouth cancers can grow substantially before becoming visible on the surface.
Palate
The hard palate is examined for any asymmetry, ulceration, or masses. The soft palate is examined with the patient's tongue depressed and mouth open, using a light to illuminate the posterior pharynx. Changes to either palate are noted and followed appropriately.
Oropharynx
The posterior oropharynx - the back of the throat, tonsillar pillars and tonsils, and posterior pharyngeal wall - is examined as completely as possible given the patient's gag reflex. This area is the primary location of HPV-related oropharyngeal cancers. Asymmetry of the tonsils, masses on the tonsillar pillars or base of tongue, and color or textural changes to the posterior pharyngeal wall are all noted.
Understanding Oral Cancer Findings - What Normal Variants Look Like
Not every soft tissue finding is cancer. The oral cavity has many normal anatomic variants and benign lesions that can appear to the untrained eye as concerning. Dr. Warya's clinical training allows her to differentiate common benign variants - linea alba, fordyce spots, tori, fibrous hyperplasia, aphthous ulcers, geographic tongue - from lesions requiring further evaluation.
When a finding cannot be definitively identified as a known benign variant, or when it shows characteristics associated with malignancy - irregular borders, mixed red and white appearance, induration (firmness on palpation), ulceration without obvious traumatic cause, or presence for more than two weeks - the appropriate response is documentation, two-week monitoring, and if persistence, referral for biopsy.
The Two-Week Rule in Oral Cancer Screening
Many oral soft tissue changes are reactive or traumatic - biting the cheek, a reaction to a sharp food, a denture sore. These resolve within one to two weeks. The two-week rule in oral cancer screening states that any soft tissue lesion without a clear benign diagnosis or obvious traumatic cause should be documented at discovery and re-evaluated in two weeks. If it has resolved, the case is closed. If it persists at two weeks, it requires further evaluation including biopsy referral.
This simple protocol prevents the clinical drift where a lesion is noticed, assumed to be benign, and informally monitored for months without formal re-examination - the scenario in which early-stage cancers progress to later stages while receiving only loose observation.
Tobacco and Oral Cancer - A Direct Conversation
For patients who use tobacco in any form, Dr. Warya includes a brief, clinical discussion of oral cancer risk and tobacco cessation at examinations where time permits. This is not a moral judgment. It is a clinical conversation about one of the most significant modifiable risk factors for one of dentistry's most serious detectable conditions.
Tobacco cessation resources in the Olathe area include the Kansas Tobacco Quitline (1-800-784-8669), nicotine replacement therapy available without prescription, and prescription pharmacotherapy through your primary care provider. Dr. Warya can coordinate with your primary care physician regarding cessation support if you are interested.